A potentially revolutionary weight-loss drug gets the green light from regulators.
This article appeared in the January/February 2022 issue ofObesity is a modern scourge, affecting 42 percent of Americans and raising overall risk of cardiovascular disease, diabetes and cancer. It is also notoriously difficult to control; for most people, diet and exercise offer only temporary results, even when combined with medication. Gastric bypass and similar procedures — though more effective — carry significant health risks of their own. In June, however, the U.S.
In a 68-week study of nearly 2,000 patients, those who received weekly injections of semaglutide lost an average of 15 percent of their body weight, or roughly 34 pounds. More than one-third shed 20 percent or more, comparable to bariatric surgery. Side effects, mostly gastrointestinal, were typically mild and transient.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Local news enters new era, reshaped by the pandemic and industry shiftsNew, independent digital outlets and nonprofits have begun to fill some of the gap left by fading local newspapers.
Read more »
Dressing 'West Side Story' for a new eraCostume designer Paul Tazewell chose distinct color palettes to help audiences track the opposing groups whether they were dancing in the school gym or fighting in the street.
Read more »
Times Square New Year's Eve ball gets new lookNew crystals from Irish company Waterford have joined over 2,000 sparkling triangles covering the ball that drops over New York's Times Square every year, days before the countdown to 2022.
Read more »
Marque Luxury opens new location in New YorkPre-owned luxury provider Marque Luxury is expanding in New York.
Read more »
New Waterford crystals added to Times Square's New Year's Eve ballNew Waterford crystals joined over 2,000 sparkling triangles covering the ball that drops over New York's Times Square every year, days before the countdown to 2022.
Read more »